FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1755311000001101: Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2156461000001111 Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2156471000001118 Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Is a Methyldopa 125mg tablets 250 tablet true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Is pack of Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) false Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has active ingredient Methyldopa false Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has AMP Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has specific active ingredient Methyldopa true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start